Page last updated: 2024-09-04

rhodioloside and alpha-synuclein

rhodioloside has been researched along with alpha-synuclein in 1 studies

Compound Research Comparison

Studies (rhodioloside)	Trials (rhodioloside)	Recent Studies (post-2010) (rhodioloside)	Studies (alpha-synuclein)	Trials (alpha-synuclein)	Recent Studies (post-2010) (alpha-synuclein)
621	2	519	10,821	29	8,011

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, F; Chen, S; Gu, C; Mao, G; Wang, G; Wang, J; Yan, J; Yang, Z	1

Other Studies

1 other study(ies) available for rhodioloside and alpha-synuclein

Article	Year
Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling. Molecular medicine reports, 2019, Volume: 20, Issue:1 Topics: alpha-Synuclein; Autophagy; Cell Line; Glucosides; Humans; Neuroprotective Agents; Parkinson Disease; Phenols; Point Mutation; Rhodiola; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases	2019

Article

Year

Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling.

Molecular medicine reports, 2019, Volume: 20, Issue:1

Topics: alpha-Synuclein; Autophagy; Cell Line; Glucosides; Humans; Neuroprotective Agents; Parkinson Disease; Phenols; Point Mutation; Rhodiola; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases

2019